High potency factor VIII concentrates: value not proved?
Cash
J D
JD
Scottish National Blood Transfusion Service, Headquarters Medical Unit, Edinburgh.
D003362:Cost-Benefit Analysis; D005169:Factor VIII / Q000008:administration & dosage / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy / Q000191:economics; D006801:Humans; D008389:Marketing of Health Services; D011787:Quality of Health Care
D005169:Factor VIII